
| Cat. No. |
Size |
Price |
Figures |
RP10835-1 mg
| 1 mg | $ 42.75 | COA: 20080213213319 (PDF) MSDS: 20080728032601 (PDF)
References:
- Shainoff JR, et al. Allosteric effects potentiating the release of the second fibrinopeptide A from fibrinogen by thrombin. J. Biol. Chem. May 2002; 277(22): 19367-19373.
- Sonel A, et al. Prospective study correlating fibrinopeptide A, troponin I, myoglobin, and myosin light chain levels with early and late ischemic events in consecutive patients presenting to the emergency department with chest pain. Circulation. Sep 2000; 102(10): 1107-1113.
- Zito F, et al. Epidemiological and genetic associations of activated factor XII concentration with factor VII activity, fibrinopeptide A concentration, and risk of coronary heart disease in men. Circulation. Oct 2000; 102(17): 2058-2062.
|
|---|
RP10835-5 mg
| 5 mg | $ 171.00 |
|---|
| Full Name | |
Sequence (one-letter code) |
ADSGEGDFLAEGGGVR | Sequence (three-letter code) | {ALA}{ASP}{SER}{GLY}{GLU}{GLY}{ASP}{PHE}{LEU}{ALA} {GLU}{GLY}{GLY}{GLY}{VAL}{ARG} | | Description | Fibrinopeptide A is released from fibrinogen on thrombin action. It is useful as a tumor marker for circumscribed and disseminated gastric cancers. Higher levels have been found in nephrotic patients. Fibrinopeptide A is also used to detect hypercoagulable state in individuals with atrial fibrillation and in underlying activation of blood coagulation. In vivo, fibrinopeptide A is used as a marker to determine the rate of conversion of fibrinogen to fibrin by thrombin. |
|---|
| Formula | C63H97N19O26 | | M.W. | 1536.6 | | Cas | 25422-31-5 |
|---|
| Purity | > 95% | | Storage | Store the peptide at -20°C. Keep container tightly closed. |
| * For Non-Clinical Research Use Only *If you cannot find your peptides on our list, try our Express PeptideTM Service, and receive high-quality peptides in eight business days, guaranteed. Our customer service is available 24 hours a day, Monday through Friday. You may contact us any time for assistance.
|
|